These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 34208136)

  • 1. NOX2 Activation in COVID-19: Possible Implications for Neurodegenerative Diseases.
    Sindona C; Schepici G; Contestabile V; Bramanti P; Mazzon E
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34208136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and neurodegenerative diseases.
    Fu YW; Xu HS; Liu SJ
    Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4535-4544. PubMed ID: 35776055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms highlighting the potential role of COVID-19 in the development of neurodegenerative diseases.
    Rahmani B; Ghashghayi E; Zendehdel M; Baghbanzadeh A; Khodadadi M
    Physiol Int; 2022 Jun; 109(2):135-162. PubMed ID: 35895572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells.
    Youn JY; Zhang Y; Wu Y; Cannesson M; Cai H
    Redox Biol; 2021 Oct; 46():102099. PubMed ID: 34509916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
    Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
    Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
    Murta V; Villarreal A; Ramos AJ
    ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
    Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F
    Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2 in the CNS.
    Szabo MP; Iba M; Nath A; Masliah E; Kim C
    Exp Mol Med; 2022 Apr; 54(4):447-454. PubMed ID: 35396576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.
    Behl T; Kaur G; Sehgal A; Bhardwaj S; Singh S; Buhas C; Judea-Pusta C; Uivarosan D; Munteanu MA; Bungau S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialogue between Neuroinflammation and Neurodegenerative Diseases in COVID-19.
    Chowdhury B; Sharma A; Satarker S; Mudgal J; Nampoothiri M
    J Environ Pathol Toxicol Oncol; 2021; 40(3):37-49. PubMed ID: 34587403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 and myocardial injury: a role for Nox2?
    Violi F; Pastori D; Pignatelli P; Cangemi R
    Intern Emerg Med; 2020 Aug; 15(5):755-758. PubMed ID: 32399954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems Bioinformatics Reveals Possible Relationship between COVID-19 and the Development of Neurological Diseases and Neuropsychiatric Disorders.
    Onisiforou A; Spyrou GM
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and olfactory dysfunction: A possible associative approach towards neurodegenerative diseases.
    Mahalaxmi I; Kaavya J; Mohana Devi S; Balachandar V
    J Cell Physiol; 2021 Feb; 236(2):763-770. PubMed ID: 32697344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 in age-related neurodegenerative diseases: is there a role for vitamin D3 as a possible therapeutic strategy?
    de Barros Viana M; Rosário BDA; de Fátima Santana de Nazaré M; Estadella D; Ribeiro DA; Socorro de Barros Viana G
    Rev Neurosci; 2021 Feb; 32(2):235-247. PubMed ID: 33185582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Mechanisms of SARS-CoV-2/COVID-19 Pathogenicity on the Central Nervous System: Bridging Experimental Probes to Clinical Evidence and Therapeutic Interventions.
    Groppa SA; Ciolac D; Duarte C; Garcia C; Gasnaș D; Leahu P; Efremova D; Gasnaș A; Bălănuță T; Mîrzac D; Movila A
    Adv Exp Med Biol; 2022; 1376():1-27. PubMed ID: 34735712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
    Rohilla S
    Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications.
    Ong WY; Go ML; Wang DY; Cheah IK; Halliwell B
    Mol Neurobiol; 2021 Jan; 58(1):106-117. PubMed ID: 32897518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of COVID-19 On Comorbidities: A Review Of Recent Updates For Combating It.
    Ahmad Malik J; Ahmed S; Shinde M; Almermesh MHS; Alghamdi S; Hussain A; Anwar S
    Saudi J Biol Sci; 2022 May; 29(5):3586-3599. PubMed ID: 35165505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the Immunologic Characteristics of Neurologic Manifestations of SARS-CoV-2 and Potential Immunological Mechanisms.
    Mohammadi S; Moosaie F; Aarabi MH
    Mol Neurobiol; 2020 Dec; 57(12):5263-5275. PubMed ID: 32869183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.